33 Special Types of Invasive Breast Carcinoma: Diagnostic Criteria ...
33 Special Types of Invasive Breast Carcinoma: Diagnostic Criteria ...
33 Special Types of Invasive Breast Carcinoma: Diagnostic Criteria ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
cases. In this small tubular carcinoma group there were no axillary metastases in 14<br />
patients; “pure” tubular carcinoma was defined as exclusively tubular differentiation<br />
with or without concomitant DCIS. But, this practice remains controversial; and, in<br />
contrast, Elson et al. (14) found metastatic tubular carcinoma in axillary lymph nodes<br />
in 4 (29%) <strong>of</strong> 14 patients who had had axillary dissections, three <strong>of</strong> whom had a<br />
primary tumor 1.0 cm or less in diameter. But in the latter series the tubular carcinoma<br />
had to have 75% or more <strong>of</strong> the classic tubular pattern to qualify. In another study <strong>of</strong><br />
50 patients with tubular carcinoma, Winchester et al. (15) noted a 20% incidence <strong>of</strong><br />
axillary nodal metastases that could not be predicted by any features displayed by the<br />
primary tumors.<br />
The average frequency <strong>of</strong> axillary lymph node metastases in patients with “mixed”<br />
tubular and ductal carcinomas is 34% (12). Because <strong>of</strong> these reports, I believe it is best<br />
to require that 90% or more <strong>of</strong> the tumor be <strong>of</strong> the classic invasive tubular pattern<br />
before a diagnosis <strong>of</strong> “pure” tubular carcinoma can be made, and the closer to 100%<br />
the better. <strong>Invasive</strong> cribriform carcinoma, even <strong>of</strong> “pure” variety, appears to<br />
metastasize more frequently to axillary lymph nodes (i.e., ~40% in one series)(7).<br />
In view <strong>of</strong> the extremely favorable prognosis <strong>of</strong> tubular/cribriform carcinoma, there is<br />
little evidence that systemic adjuvant therapy would prove beneficial, except possibly<br />
for women with axillary metastases or if there is also a less well-differentiated carcinoma<br />
in the ipsilateral or contralateral breast. Patients with mixed tubular/ductal or<br />
mixed cribriform/ductal carcinomas should receive treatment appropriate for an<br />
infiltrating duct carcinoma <strong>of</strong> the grade <strong>of</strong> the non-tubular component as determined<br />
by tumor size and stage.<br />
Clinicopathologic features: Tubular carcinomas are either incidental findings or<br />
discovered as small, stellate mass lesions. The gross appearance is similar to that <strong>of</strong><br />
benign lesions such as sclerosing papillary lesions (aka, "radial scar") (16). <strong>Invasive</strong><br />
cribriform carcinomas can present in a similar fashion, but more <strong>of</strong>ten form firm mass<br />
lesions with no distinctive features. Both tumor types, including the mixed forms, may<br />
be multifocal in a significant number <strong>of</strong> patients (i.e., ~20%) (13). About 8% <strong>of</strong><br />
invasive carcinomas 1 cm or less in diameter are tubular carcinomas (17). Most<br />
tubular carcinomas are 2 cm or less in diameter, but some as large as 4 cm have been<br />
reported (5,11,18). This tumor is more common in older patients but the age at<br />
diagnosis is ranging from 24 to 92 years (11,18,19). For invasive cribriform<br />
carcinoma, at least one male and 113 female patients (ranging in age from 19 to 86<br />
years) have been described (6,7,20). In my experience, when studied by immunohistochemistry,<br />
both tubular and cribriform carcinomas have always been hormone<br />
46